InvestorsHub Logo
Followers 20
Posts 1631
Boards Moderated 0
Alias Born 11/10/2010

Re: None

Friday, 08/18/2017 4:34:00 PM

Friday, August 18, 2017 4:34:00 PM

Post# of 7185
RVNC - A very thorough analysis on Revance and the botulinum toxin market. One of the better articles I've read on seeking alpha.

Revance Therapeutics: An Undervalued Botox Competitor
https://seekingalpha.com/article/4099801-revance-therapeutics-undervalued-botox-competitor
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News